Silvana Maria Eloi-Santos
J. Bras. Patol. Med. Lab. 2015;51(6):358
In 2009, the US Food and Drug Administration (FDA) approved the Clinical and Laboratory Standards Institute ([CLSI] – formerly NCCLS) consensus standard for auto verification of clinical laboratory test results(1). That guideline provides a general framework that allows clinical laboratories to propose, implement, validate, and customize their own rules for auto verification. The endorsed verifications include limit check rules, critical values, comparison with former results, and consistency of related results(1). Thus, auto verification turns into a powerful tool to improve post-analytical laboratory process, increasing efficiency and reducing overall turnaround time.
Since then, several studies have been published reporting the efficiency of the implementation of the autoverification process. In this issue of the Jornal Brasileiro de Patologia e Medicina Laboratorial ( JBPML), we have an original report describing the implementation of auto verification of the automated blood cell counter (CBC) in a reference laboratory in Bogota, Colombia, where the authors state that the auto verification percentage has reached 60% of the automated blood cell counters in their laboratory. In addition, a significant reduction in non-conforming products, possibly attributable to errors in manual verification, was achieved(2). This is another indication that the auto verification system provides many benefits for laboratories regarding error reduction, optimization in the process flow and reduction in turnaround times. Read More …